Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lovastatin as a Potential Modulator of Apoptosis in COPD

NCT00700921 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT00700921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00700921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lovastatin as a Potential Modulator of Apoptosis in COPD
Lead sponsor
National Jewish Health
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2008
Completion date
November 30, 2012
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)